Recombinant Human Platelet–Derived Growth Factor: A Systematic Review of Clinical Findings in Oral Regenerative Procedures

AIM: The use of recombinant human platelet-derived growth factor–BB (rhPDGF) has received Food and Drug Administration approval for the treatment of periodontal and orthopedic bone defects and dermal wound healing. Many studies have investigated its regenerative potential in a variety of other oral...

Full description

Saved in:
Bibliographic Details
Published in:JDR Clin Trans Res
Main Authors: Tavelli, L., Ravidà, A., Barootchi, S., Chambrone, L., Giannobile, W.V.
Format: Artigo
Language:Inglês
Published: SAGE Publications 2020
Subjects:
Reviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7961612/
https://ncbi.nlm.nih.gov/pubmed/32392438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2380084420921353
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items